Delivery Order SPE2DB22D2108-SPE2DB25FU2UP
Award Date
11/26/24
Potential Completion Date
11/27/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,888.95, is for the supply of XHANCE 93 MCG NASAL SPRAY 16ML, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a completion date of February 26, 2025. The contract is not designated as a set-aside and was open to full and open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,436.26, is for the delivery of XHANCE 93 MCG Nasal Spray 16ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of December 18, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,467.65, is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML, a pharmaceutical product. The contract is a Firm Fixed Price, Delivery Order contract with a completion date of June 25, 2024. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XHANCE 93 MCG NASAL SPRAY 16ML. The $4,281.82 firm fixed-price delivery order has a completion date of December 10, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,294.97, is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML. It is a firm fixed-price contract with a period of performance ending on May 8, 2023. The contract was awarded on May 5, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,329.80, is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML. This is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,161.81 firm fixed-price delivery order is for the supply of XHANCE 93 MCG NASAL SPRAY 16ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XHANCE 93 MCG Nasal Spray. The contract has a ceiling value of $1,332.09 and is a firm fixed-price contract with a period of performance through March 24, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical on April 30, 2024. The order is for the supply of XHANCE 93 MCG NASAL SPRAY 16ML, a pharmaceutical product, with a ceiling value of $1,652.62 and a completion date of May 1, 2024. The contract is a firm fixed price delivery order and is not set aside for any specific business type. Amerisourcebergen is a major supplier of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,600.73 contract is for the supply of XHANCE 93 MCG NASAL SPRAY 16ML to support federal healthcare programs. The award is not associated with a set-aside program and is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...